Cargando…

Performance comparison of the cobas Liat and Cepheid GeneXpert systems for Clostridium difficile detection

Clostridium difficile infection (CDI) is a high burden and significant cause of healthcare-acquired infectious diarrhea in the United States (US). Timely and accurate diagnosis of CDI enables the rapid initiation of antibiotic therapy and infection control policies to minimize disease transmission....

Descripción completa

Detalles Bibliográficos
Autores principales:	Granato, Paul A., Hansen, Glen, Herding, Emily, Chaudhuri, Sheena, Tang, Shaowu, Garg, Sachin K., Rowell, Catherine R., Sickler, Joanna Jackson
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057633/ https://www.ncbi.nlm.nih.gov/pubmed/30040852 http://dx.doi.org/10.1371/journal.pone.0200498

Ejemplares similares

Molecular point-of-care testing for influenza A/B and respiratory syncytial virus: comparison of workflow parameters for the ID Now and cobas Liat systems
por: Young, Stephen, et al.
Publicado: (2020)

Equivalent Performance of the Cobas(®) Cdiff Test for Use on the Cobas(®) Liat(®) System and the Cobas(®) 4800 System
por: Garg, Sachin K, et al.
Publicado: (2017)

Recommendations for sample pooling on the Cepheid GeneXpert(®) system using the Cepheid Xpert(®) Xpress SARS-CoV-2 assay
por: Becker, Michael G., et al.
Publicado: (2020)

Clinical Performance of the Point-of-Care cobas Liat for Detection of SARS-CoV-2 in 20 Minutes: a Multicenter Study
por: Hansen, Glen, et al.
Publicado: (2021)

Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges
por: Broder, Kari, et al.
Publicado: (2020)

Clinical utility of the GeneXpert assay for the diagnosis of Clostridium difficile infections
por: Florea, Dragoş, et al.
Publicado: (2014)

Analytical Performance Characteristics of the Cepheid GeneXpert Ebola Assay for the Detection of Ebola Virus
por: Pinsky, Benjamin A., et al.
Publicado: (2015)

Performance and usability of Cepheid GeneXpert HIV-1 qualitative and quantitative assay in Kenya
por: Bwana, Priska, et al.
Publicado: (2019)

Correction: Analytical Performance Characteristics of the Cepheid GeneXpert Ebola Assay for the Detection of Ebola Virus
por: Pinsky, Benjamin A., et al.
Publicado: (2015)

Comparing the cobas Influenza A/B Nucleic acid test for use on the cobas Liat System (Liat) with rapid antigen tests for clinical management of Japanese patients at the point of care
por: Mikamo, Hiroshige, et al.
Publicado: (2022)

Field evaluation of near point of care Cepheid GeneXpert HIV-1 Qual for early infant diagnosis
por: Opollo, Valarie Sarah, et al.
Publicado: (2018)

Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
por: Smithgall, Marie C., et al.
Publicado: (2020)

Evaluation of the Cepheid Xpert C. difficile diagnostic assay: an update meta-analysis
por: Bai, Yuanyuan, et al.
Publicado: (2021)

Field Evaluation of the Cepheid GeneXpert Chlamydia trachomatis Assay for Detection of Infection in a Trachoma Endemic Community in Tanzania
por: Jenson, Alexander, et al.
Publicado: (2013)

Evaluation of the Liat Cdiff Assay for Direct Detection of Clostridioides difficile Toxin Genes within 20 Minutes
por: Hetem, David J., et al.
Publicado: (2019)

Field evaluation of GeneXpert(®) (Cepheid) HCV performance for RNA quantification in a genotype 1 and 6 predominant patient population in Cambodia
por: Iwamoto, Momoko, et al.
Publicado: (2018)

Clinical performance of SARS-CoV-2 detection on the cobas Liat using water gargle samples()
por: Veillette, Maxime, et al.
Publicado: (2022)

Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection
por: Georghiou, Sophia B., et al.
Publicado: (2021)

Evaluation of the Xpert Clostridium difficile Assay for the Diagnosis of Clostridium difficile Infection
por: Shin, Saeam, et al.
Publicado: (2012)

2179. Detection of Group A Streptococcus in the Saliva of Children Presenting With Pharyngitis Using the cobas®LIAT® PCR System
por: DeMuri, Gregory P, et al.
Publicado: (2019)

Clinical Performance of the cobas Liat SARS-CoV-2 & Influenza A/B Assay in Nasal Samples
por: Akashi, Yusaku, et al.
Publicado: (2022)

Detection of Clostridium difficile antigen and toxin in stool specimens: Comparison of the C. difficile quik chek complete enzyme immunoassay and GeneXpert C. difficile polymerase chain reaction assay
por: Senok, Abiola C., et al.
Publicado: (2017)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

SARS-CoV-2 Testing of Emergency Department Patients Using cobas(®) Liat(®) and eazyplex(®) Rapid Molecular Assays
por: Egerer, Renate, et al.
Publicado: (2023)

Multicenter Evaluation of the Cepheid Xpert(®) HBV Viral Load Test
por: Marcuccilli, Fabbio, et al.
Publicado: (2021)

Multicenter Evaluation of the Cepheid Xpert GBS LB XC Test
por: Thwe, Phyu M., et al.
Publicado: (2022)

Evaluation of the GeneXpert for Human Monkeypox Diagnosis
por: Li, Daniel, et al.
Publicado: (2017)

GeneXpert for the diagnosis of COVID-19 in LMICs
por: Rakotosamimanana, Niaina, et al.
Publicado: (2020)

Contributions of GeneXpert(®) to TB diagnosis in Myanmar
por: Burger, Z., et al.
Publicado: (2022)

Accuracy of Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection: A meta analysis
por: Bai, Yuanyuan, et al.
Publicado: (2017)

Discordant SARS-CoV-2 RNA results obtained using the Roche cobas Liat SARS-CoV-2
por: Warnock, Gayle, et al.
Publicado: (2022)

GeneXpert—A Game-Changer for Tuberculosis Control?
por: Evans, Carlton A.
Publicado: (2011)

GeneXpert for TB diagnosis: planned and purposeful implementation
por: Piatek, Amy S, et al.
Publicado: (2013)

GeneXpert in stool: Diagnostic yield in Intestinal Tuberculosis
por: Talib, Abu, et al.
Publicado: (2019)

WHO laboratory validation of Xpert(®) CT/NG and Xpert(®) TV on the GeneXpert system verifies high performances
por: Jacobsson, Susanne, et al.
Publicado: (2018)

Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay
por: Graham, Maryza, et al.
Publicado: (2021)

Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test
por: Loeffelholz, Michael J., et al.
Publicado: (2020)

Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2014)

Public investments in the development of GeneXpert molecular diagnostic technology
por: Gotham, Dzintars, et al.
Publicado: (2021)

Evaluation of the cobas Liat detection test for SARS-CoV-2 and influenza viruses following the emergence of the SARS-CoV-2 Omicron variant
por: Park, Kuenyoul, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f5kkd14dcrtcekgv12deb4eddu